Your browser doesn't support javascript.
loading
Serostatus cutoff levels and fold increase to define seroresponse to recombinant vesicular stomatitis virus - Zaire Ebola virus envelope glycoprotein vaccine: An evidence-based analysis.
Antonello, Joseph; Grant-Klein, Rebecca J; Nichols, Rick; Kennedy, Stephen B; Dubey, Sheri; Simon, Jakub K.
  • Antonello J; Merck & Co., Inc., Kenilworth, NJ, USA. Electronic address: joseph_antonello@merck.com.
  • Grant-Klein RJ; Merck & Co., Inc., Kenilworth, NJ, USA. Electronic address: rebecca.klein1@merck.com.
  • Nichols R; Crozet BioPharma LLC., Devens, MA, USA. Electronic address: rick.nichols@crozetbiopharma.com.
  • Kennedy SB; Partnership for Research on Ebola Virus in Liberia (PREVAIL), Monrovia, Liberia. Electronic address: sbkennedy4@aol.com.
  • Dubey S; Merck & Co., Inc., Kenilworth, NJ, USA. Electronic address: sheri_dubey@merck.com.
  • Simon JK; Merck & Co., Inc., Kenilworth, NJ, USA. Electronic address: jakub.simon@merck.com.
Vaccine ; 38(31): 4885-4891, 2020 06 26.
Article en En | MEDLINE | ID: mdl-32499064

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fiebre Hemorrágica Ebola / Vacunas contra el Virus del Ébola / Ebolavirus / Estomatitis Vesicular Tipo de estudio: Clinical_trials / Systematic_reviews Límite: Animals / Humans País como asunto: Africa Idioma: En Año: 2020 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fiebre Hemorrágica Ebola / Vacunas contra el Virus del Ébola / Ebolavirus / Estomatitis Vesicular Tipo de estudio: Clinical_trials / Systematic_reviews Límite: Animals / Humans País como asunto: Africa Idioma: En Año: 2020 Tipo del documento: Article